CT Health Commissioner Supports Pediatric Vaccine Guidelines Over CDC

Jan 31, 2026, 2:19 AM
Image for article CT Health Commissioner Supports Pediatric Vaccine Guidelines Over CDC

Hover over text to view sources

Connecticut's Health Commissioner, Manisha Juthani, MD, has publicly backed the vaccine recommendations from the American Academy of Pediatrics (AAP) over the recently revised guidelines from the Centers for Disease Control and Prevention (CDC). This decision is part of a growing trend among states that are pushing back against the CDC's changes to the childhood vaccine schedule, initiated on January 5 of this year, which reduced the number of universally recommended vaccinations from 17 to 11.
In her statement, Juthani emphasized the importance of aligning with organizations that have a long-standing reputation for evidence-based medical advice. The AAP continues to support the previous CDC immunization schedule, which many health officials argue is essential for maintaining public health standards.
This divergence has gained traction across the US, with at least 20 states, including Connecticut, rejecting the new CDC vaccine schedule. Health officials in these states argue that the CDC's new recommendations are not only confusing but also pose risks to public health, particularly in light of recent outbreaks of measles and whooping cough. Massachusetts Public Health Commissioner Robbie Goldstein called the CDC's changes "reckless and deeply dangerous," asserting that such a shift undermines decades of scientific research and public health guidance.
Juthani's support for the AAP's guidelines reflects a broader commitment among various states to maintain consistent and science-driven vaccine policies, especially as the federal government experiences fluctuations in its health recommendations. In Connecticut, the Department of Public Health (DPH) has released interim guidance emphasizing vaccination as the most effective defense against severe respiratory illnesses, aligning closely with the AAP's stance.
The move has received backing not only from Connecticut but also from health officials in states like California and Minnesota, where similar sentiments have been expressed. These officials stress that clear and consistent communication regarding vaccines is crucial for maintaining public trust and ensuring community health.
In response to the CDC's changes, a coalition of health officials from various states has formed alliances to coordinate their vaccination policies. The West Coast Health Alliance, which includes states like California, Oregon, and Washington, as well as the Northeast Public Health Collaborative, encompassing states like New York and New Jersey, aim to provide unified, science-based health recommendations.
These alliances have emerged as a countermeasure to the perceived erosion of trust in federal health agencies, particularly following leadership changes within the CDC that have raised concerns about transparency and the integrity of public health guidance.
Furthermore, the AAP, alongside over 200 health organizations, has urged Congress to investigate the abrupt changes to the childhood vaccine schedule, advocating for a return to evidence-based practices that prioritize the health of children and communities.
As the debate continues, the emphasis remains on providing access to vaccines that are grounded in scientific evidence, rather than political agendas. Juthani and other health officials are committed to ensuring that vaccine policies in Connecticut reflect expert consensus and prioritize the health and safety of residents.
With legislative initiatives being introduced in various states to bypass federal guidelines and uphold local health standards, it is clear that the issue of vaccine policy is far from settled. The focus on maintaining public health through evidence-based recommendations will likely continue to shape the landscape of vaccination in the coming months.
As Connecticut and other states navigate the complexities of vaccine policy amidst federal changes, health officials are emphasizing the importance of public trust and clear communication to ensure that communities remain protected against preventable diseases.
The situation highlights a critical moment in public health, where the decisions made by states and local health officials may have long-lasting effects on vaccination rates and public health outcomes for years to come.

Related articles

Experts Warn HHS Vaccine Policy Changes Violate Law and Endanger Health

Legal and public health experts are raising alarms over recent changes made by the US Department of Health and Human Services to vaccination guidelines. They argue that these modifications, which downgrade the status of several vaccines, violate federal law and could significantly jeopardize public health, particularly for children and pregnant individuals.

Former FDA Chief Critiques HHS for Policy-Based Evidence Approach

Dr Robert M. Califf, former FDA Commissioner, has expressed concerns regarding the current leadership of the Department of Health and Human Services (HHS), suggesting that it emphasizes policy-based evidence rather than evidence-based policy. This shift may undermine public health initiatives and the integrity of vaccine recommendations.

SC Senator Proposes Bill to Eliminate Religious Exemptions for Measles Vaccine

South Carolina State Senator Margie Bright Matthews has introduced a bill to abolish religious exemptions for the measles vaccine, aiming to improve public health amid a significant outbreak in the state. The proposal has sparked debate, with critics arguing it infringes on religious freedoms.

Trust in CDC at Low Point Amid Vaccine Schedule Changes

A recent KFF Tracking Poll reveals a significant decline in public trust towards the CDC, with less than half of Americans expressing confidence in the agency's vaccine guidance. The poll highlights partisan divides regarding the newly revised childhood vaccination schedule, with many expressing concerns about its impact on children's health.

President Trump Launches TrumpRx to Make Medicines More Affordable

On February 5, President Donald Trump unveiled TrumpRx, a new initiative aimed at providing cost-effective medications to Americans. The program, set to launch in 2026, is expected to significantly reduce prices for popular GLP-1 weight loss medications, making them accessible to more individuals.